Tissue kallikrein promotes cardiac neovascularization by enhancing endothelial progenitor cell functional capacity

Human Gene Therapy

Volumn 23, Issue 8, 2012, Pages 859-870

  Yao, Yuyu ^a   Sheng, Zulong ^a   Li, Yefei ^a   Yan, Fengdi ^a   Fu, Cong ^a   Li, Yongjun ^a   Ma, Genshan ^a   Liu, Naifeng ^a   Chao, Julie ^b   Chao, Lee ^b  

^a MEDICAL SCHOOL OF SOUTHEAST UNIVERSITY   (China)

^b MEDICAL UNIVERSITY OF SOUTH CAROLINA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

2 MORPHOLINO 8 PHENYLCHROMONE; ADENOVIRUS VECTOR; CASPASE 3; ICATIBANT; PROTEIN KINASE B; TISSUE KALLIKREIN;

ANGIOGENESIS; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; APOPTOSIS; ARTICLE; CD34 SELECTION; CELL DIFFERENTIATION; CELL FUNCTION; CELL MIGRATION; CONTROLLED STUDY; ENDOTHELIAL PROGENITOR CELL; FAR WESTERN BLOTTING; FLOW CYTOMETRY; GENE TARGETING; GENETIC TRANSDUCTION; HEART FUNCTION; HEART INFARCTION; HEART INFARCTION SIZE; HEART LEFT VENTRICLE FUNCTION; HEART MUSCLE CONTRACTILITY; HYPOXIA; IN VITRO STUDY; IN VIVO STUDY; MALE; MORTALITY; MOUSE; NEOVASCULARIZATION (PATHOLOGY); NONHUMAN; PERIPHERAL BLOOD MONONUCLEAR CELL; PERIPHERAL CIRCULATION; PROTEIN PHOSPHORYLATION; RAT;

ADENOVIRIDAE; ANIMALS; ANTIGENS, CD3; CASPASE 3; CELL DIFFERENTIATION; CELL MOVEMENT; CELLS, CULTURED; ENDOTHELIAL CELLS; GENETIC VECTORS; HUMANS; MALE; MICE; MYOCARDIAL CONTRACTION; MYOCARDIAL INFARCTION; MYOCARDIUM; MYOCYTES, CARDIAC; NEOVASCULARIZATION, PHYSIOLOGIC; PROTO-ONCOGENE PROTEINS C-AKT; RATS; SIGNAL TRANSDUCTION; STEM CELLS; TISSUE KALLIKREINS;

EID: 84865259847     PISSN: 10430342     EISSN: 15577422     Source Type: Journal    
DOI: 10.1089/hum.2011.123     Document Type: Article

References (30)

1. Chavakis, E, Urbich, C., and Dimmeler, S. (2008). Homing and engraftment of progenitor cells: a prerequisite for cell therapy. J. Mol. Cell. Cardiol. 45, 514-522.
2. Ebrahimian, T.G., Heymes, C., You, D., et al. (2006). NADPH oxidase-derived overproduction of reactive oxygen species impairs postischemic neovascularization in mice with type 1 diabetes. Am. J. Pathol. 169, 719-728.
3. Emanueli, C., Zacheo, A., Minasi, A., et al. (2000). Adenovirus-mediated human tissue kallikrein gene delivery induces an-giogenesis in normoperfused skeletal muscle. Arterioscler. Thromb. Vasc. Biol. 20, 2379-2385.
4. George, J., Goldstein, E., Abashidze, S., et al. (2004). Circulating endothelial progenitor cells in patients with unstable angina: association with systemic inflammation. Eur. Heart J. 12, 1003-1008.
5. George, J., Shmilovich, H., Deutsch, V., et al. (2006). Comparative analysis of methods for assessment of circulating endothelial progenitor cells. Tissue Eng. 12, 331-335.
6. Griol-Charhbili, V., Messadi-Laribi, E., Bascands, J.L., et al. (2005). Role of tissue kallikrein in the cardioprotective effects of ischemic and pharmacological preconditioning in myocar-dial ischemia. FASEB J. 19, 1172-1174.
7. Heeschen, C., Aicher, A., Lehmann, R., et al. (2003). Ery-thropoietin is a potent physiologic stimulus for endothelial progenitor cell mobilization. Blood 102, 1340-1346.
8. Hill, J.M., Zalos, G., Halcox, J.P.J., et al. (2003). Circulating en-dothelial progenitor cells, vascular function, and cardiovascular risk. N. Engl. J. Med. 348, 593-600.
9. Isner, J.M., and Asahara, T. (1999). Angiogenesis and vasculo-genesis as therapeutic strategies for postnatal neovascular-ization. J. Clin. Invest.103, 1231-1236.
10. Kawamoto, A., Gwon, H.C., Iwaguro, H., et al. (2001). Therapeutic potential of ex vivo expanded endothelial progenitor cells for myocardial ischemia. Circulation 103, 634-637.
11. Kocher, A.A., Schuster, M.D., Szabolcs, M.J., et al. (2001). Neo-vascularization of ischemic myocardium by human bone-marrow-derived angioblasts prevents cardiomyocyte apoptosis, reduces remodeling and improves cardiac function. Nat. Med. 7, 430-436.
12. Kränkel, N., Katare, R.G., Siragusa, M., et al. (2008). Role of kinin B2 receptor signaling in the recruitment of circulating progenitor cells with neovascularization potential. Circ. Res. 103, 1335-1343.
13. Loomans, C.J., de Koning, E.J., Staal, F.J., et al. (2004). En-dothelial progenitor cell dysfunction: a novel concept in the pathogenesis of vascular complications of type 1 diabetes. Diabetes 53, 195-199.
14. Madeddu, P., Emanueli, C., and El-Dahr, S. (2007). Mechanisms of disease: the tissue kallikrein-kinin system in hypertension and vascular remodeling. Nat. Clin. Pract. Nephrol. 3, 208-221.
15. Pons, S., Griol-Charhbili, V., Heymes, C., et al. (2008). Tissue kallikrein deficiency aggravates cardiac remodelling and decreases survival after myocardial infarction in mice. Eur. J. Heart Fail. 10, 343-351.
16. Serhan, C.N., Fierro, I.M., Chiang, N., and Pouliot, M. (2001). Cutting edge: nociceptin stimulates neutrophil chemotaxis and recruitment: inhibition by aspirin-triggered-15-epi-lipoxin A4. J. Immunol. 166, 3650-3654.
17. Silva, J.-A., Jr., Araujo, R.C., Baltatu, O., et al. (2000). Reduced cardiac hypertrophy and altered blood pressure control in transgenic rats with the human tissue kallikrein gene. FASEB J. 14, 1858-1860.
18. Spillmann, F., Graiani, G., Van Linthout, S., et al. (2006). Regional and global protective effects of tissue kallikrein gene delivery to the peri-infarct myocardium. Regen. Med. 1, 235-254.
19. Spinetti, G., Fortunato, O., Cordella, D., et al. (2011). Tissue kallikrein is essential for invasive capacity of circulating proangiogenic cells. Circ. Res.108, 284-293.
20. Stone, O.A., Richer, C., Emanueli, C., et al. (2009). Critical role of tissue kallikrein in vessel formation and maturation: implications for therapeutic revascularization. Arterioscler. Thromb. Vasc. Biol. 29, 657-664.
21. Thum, T., Fraccarollo, D., Schultheiss, M., et al. (2007). En-dothelial nitric oxide synthase uncoupling impairs endothelial progenitor cell mobilization and function in diabetes. Diabetes 56, 666-674.
22. Toma, C., Pittenger, M.F., Cahill, K.S., et al. (2002). Human mesenchymal stem cells differentiate to a cardiomyocyte phenotype in the adult murine heart. Circulation 105, 93-98.
23. Vasa, M., Fichtlscherer, S., Aicher, A., et al. (2001). Number and migratory activity of circulating endothelial progenitor cells inversely correlate with risk factors for coronary artery disease. Circ. Res. 89, E1-E7.
24. Yancopoulos, G.D., Davis, S., Gale, N.W., et al. (2000). Vascular-specific growth factors and blood vessel formation. Nature 407, 242-248.
25. Yao, Y.Y., Yin, H., Shen, B., et al. (2007). Tissue kallikrein and kinin infusion rescues failing myocardium after myocardial infarction. J. Card. Fail. 13, 588-596.
26. Yao, Y.Y., Yin, H., Shen, B., et al. (2008). Tissue kallikrein promotes neovascularization and improves cardiac function by the Akt-glycogen synthase kinase-3b pathway. Cardiovasc. Res. 80, 354-364.
27. Yao, Y.Y., Li, Y., Ma, G., et al. (2011). In vivo magnetic resonance imaging of injected endothelial progenitor cells after myocar-dial infarction in rats. Mol. Imaging Biol. 13, 303-313.
28. Yin, H., Chao, L., and Chao, J. (2005). Kallikrein/kinin protects against myocardial apoptosis after ischemia/reperfusion via Akt-glycogen synthase kinase-3 and Akt-Bad.14-3-3 signaling pathways. J. Biol. Chem. 280, 8022-8030.
29. Yoshida, H., Zhang, J.J., Chao, L., and Chao, J. (2000). Kallikrein gene delivery attenuates myocardial infarction and apoptosis after myocardial ischemia and reperfusion. Hypertension 35, 25-31.
30. Zhang, J.J., Chao, L., and Chao, J. (1999). Adenovirus-mediated kallikrein gene delivery reduces aortic thickening and stroke-induced death rate in Dahl salt-sensitive rats. Stroke 30, 1925-1931.